Jake Leach is the current President & COO of Dexcom; he is poised to become CEO Jan. 1. An employee since 2004, he has led biosensing strategy, overseeing product, global ops, R&D, clinical, quality and regulatory. He helped build Dexcom’s CGM franchise from the first system to G7 and Stelo, the first FDA-cleared OTC glucose biosensor, while shaping an integrated organization for long-term growth.